IP Verse

Photo-Controlled Removal Of Targets In Vitro And In Vivo - EP3177323

The patent EP3177323 was granted to The United States OF America on Jan 25, 2023. The application was originally filed on Aug 7, 2015 under application number EP15760320A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP3177323

THE UNITED STATES OF AMERICA
Application Number
EP15760320A
Filing Date
Aug 7, 2015
Status
Patent Maintained As Amended
Dec 23, 2022
Publication Date
Jan 25, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

STRAWMANJan 30, 2020POTTER CLARKSON -

Patent Citations (21) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP0120694
DESCRIPTIONEP0125023
DESCRIPTIONEP0256654
DESCRIPTIONUS2006094026
DESCRIPTIONUS2007037171
DESCRIPTIONUS4444487
DESCRIPTIONUS4745055
DESCRIPTIONUS5530020
DESCRIPTIONUS5585089
DESCRIPTIONUS5912264
DESCRIPTIONUS6610860
DESCRIPTIONUS7192708
DESCRIPTIONUS7332283
DESCRIPTIONUS7485419
DESCRIPTIONUS7534560
DESCRIPTIONUS7612185
DESCRIPTIONUS8058415
DESCRIPTIONWO2004018478
DESCRIPTIONWO8803565
INTERNATIONAL-SEARCH-REPORTUS2014120119
OPPOSITIONWO2016022896

Non-Patent Literature (NPL) Citations (6) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
OPPOSITION- DOANE et al., "Observation and Photophysical Characterization of Silicon Phthalocyanine J‐Aggregate Dimers in Aqueous Solutions", Chemistry, (20140623), vol. 20, no. 26, doi:10.1002/chem.201304885, pages 8030 - 8039, XP055681008
OPPOSITION- SHIRASU et al., "Potent and specific antitumor effect of CEA‐targeted photoimmunotherapy", Int. J. Cancer, (20141201), vol. 135, doi:10.1002/ijc.28907, pages 2697 - 2670, XP055219746
OPPOSITION- XU et al., "Antibody conjugated magnetic iron oxide nanoparticles for cancer cell separation in fresh whole blood", Biomaterials, (20110914), vol. 32, no. 36, doi:10.1016/j.biomaterials.2011.08.076, pages 9758 - 9765, XP028316429
OPPOSITION- MITSUNAGA et al., "Near-infrared Theranostic Photoimmunotherapy (PIT): Repeated Exposure of Light Enhances the Effect of Immunoconjugate", Bionconjugate. Chem., (20120227), vol. 23, no. 3, doi:10.1021/bc200648m, pages 604 - 609, XP002683827
OPPOSITION- MITSUNAGA et al., "Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules", Nat. Med., (20110611), vol. 17, no. 12, doi:10.1038/nm.2554, pages 1685 - 1691, XP002683826
OPPOSITION- SATO et al., "Selective cell elimination in vitro and in vivo from tissues and tumors using antibodies conjugated with a near infrared phthalocyanine", RSC Adv., (20150303), vol. 5, no. 32, doi:10.1039/c4ra13835j, pages 25105 - 25114, XP055680858

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents